Tesla Falls as Musk’s Feud with Trump Escalates Over Tax Bill and EV Credits
Eli Lilly’s $1 Billion Bet On SiteOne: Can Non-Opioid Pain Drugs Reshape The Pharma Giant’s Future?
Eli Lilly has agreed to acquire SiteOne Therapeutics, a clinical-stage biotech specializing in small molecule inhibitors of sodium channels involved in pain signal transmission.
Constellation Energy Surges on Nuclear Power Deal with Meta for AI Expansion
Business & Market Movers
Stock Market Today: US Stocks Inch Higher as Trump-Xi Call Fuels Trade Optimism, Tesla Slumps
·Jun 05, 2025
Motorola’s $4.4B Bet on Battlefield Networking: What the Silvus Acquisition Could Mean For Investors!
·Jun 05, 2025Breaking News
Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled “Low Glycemic Sugar Composition.”
Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE American: DSS) has a significant investment, is thrilled to announce a milestone in its innovative Laetose™ technology platform. The U.S. Patent and Trademark Office (USPTO) has issued U.S. patent # 11,898,184, entitled “Low Glycemic Sugar Composition” developed within this platform.
Bruush Oral Care Inc. and Arrive Technology Inc. Announce Agreement and Plan of Merger
scdadmin·Dec 15, 2023
Deep Dive & Research
Healthcare & Biotech
Eli Lilly’s $1 Billion Bet On SiteOne: Can Non-Opioid Pain Drugs Reshape The Pharma Giant’s Future?
Eli Lilly has agreed to acquire SiteOne Therapeutics, a clinical-stage biotech specializing in small molecule inhibitors of sodium channels involved in pain signal transmission.
Arcutis Biotherapeutics Surges Amid Takeover Speculation: Why Large Pharma Should Pay Attention!
The Biotech Stock Soaring 63% on Unprecedented Cancer Trial Results – Meet Janux Therapeutics
Join our newsletter
Read and share new perspectives on just about any topic. Everyone’s welcome.- 01Create a free account
- 02Write your story
Tech & Energy
Tesla Falls as Musk’s Feud with Trump Escalates Over Tax Bill and EV Credits
Tesla’s stock fell steeply on Thursday, dropping as much as 8.7% after a very public fallout between Elon Musk and President Trump.
Motorola’s $4.4B Bet on Battlefield Networking: What the Silvus Acquisition Could Mean For Investors!
Zeta Global In The Spotlight: Acquisition Buzz Fuels Stock Surge After Blockbuster Quarter!
